Sunday, 21 February 2016 23:52

Good news from Naples Italy

A subscriber to the Site had an interesting find of an article published in the Journal of Surgical Research, describing the placebo controlled clinical study of PAD (Peripheral Arterial Disease) patients with chronic ulcers treated with ADRCs from Celution. By my assessment this study is one of several European Celution device based clinical studies, which culminated in Cytori receiving market authorization (added claim to Celution for intended use of: therapy against chronic wounds- reported August 2012). As described in my other article: Another backdoor Slider,  EU regulations allow the device pathway for same day surgical and AUTOLOGOUS procedures, whereby the extracted cells remain property of the patient and ONLY can be used for this SAME patient as per the "Placed on the Market" principle.  This article is presented in "key elements" style instead of my usual long stories to keep our focus on the facts-

 

Wound healing is a complex- and dynamic process of restoring cellular structures and tissue layers. The human adult wound healing process can be divided into 3 distinct phases: the inflammatory phase, the proliferative phase, and the remodeling phase.

Wouldnt it therefore be nice if we could replace this highly complex biological process, that can take months to complete for large complex wounds, by having patients using the "Holy Grail" to drink magic water taken from the "fountain of eternal youth", as Indiana Jones showed us in the movie "The last Crusade"? Yes- that would be wonderful- unfortunately realization of this fiction is far away, but ADRCs could become the "holy grail" of wound healing some day, which certainly aint fiction if you read the following

Copyright Information

Copyright Fas Kuiters © 2019-2020 raccoon-lodge.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.